STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #243 by analyst upside · 2026-08-14
HSCS
HeartSciences Inc.
Healthcare · Market Cap $8M · P/E 0x
ANALYST PRICE TARGET
+385.4%
implied upside to consensus target
Current Price $2.06
Consensus Target $10.0
Bull Target $12.0
Bear Target $8.0
Analysts Covering 2
ANALYST CONSENSUS - STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $1.63
52-Week High $3.93
YTD Return -34.4%
FUNDAMENTALS
Market Cap $8M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-3.48
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.63
52-Week High $3.93
Current Price $2.06
Bear Target $8.0
Bull Target $12.0
● Now $2.06 ● Target $10.0
TRADING DATA
Avg Volume 2.3M
YTD Return -34.4%
Analyst Count 2
Consensus Strong Buy
Upside to Target +385.4%
Last Updated 2026-08-14

ANALYST SUMMARY

HeartSciences Inc. (HSCS) is currently trading at $2.06 with a Wall Street consensus price target of $10.0, implying potential upside of 385.4% over the next 12 months. 2 analysts currently cover HSCS, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $12.0, while the most cautious has a target of $8.0.

HSCS operates in the Healthcare sector with a market capitalisation of $8M. The stock is down 34.4% year-to-date and is currently trading near the lower end of its 52-week range of $1.63 – $3.93.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for HSCS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Ascendiant Capital - Reiterated
Buy → Buy 2026-03-24 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-12-22 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-10-01 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-03-18 Building track record
Maxim Group reit
Buy → Buy 2024-12-18 28% win rate (40 calls)
Ascendiant Capital reit
Buy → Buy 2024-09-23 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →